IPM.ai

Utilizing ML, AI and RWD to find, engage and educate specialty and rare disease patients who could benefit from life saving therapies

[IPM.ai @ipm_ai]

The leading #raredisease #pharmaceuticalcompanies have experienced unprecedented success uncovering undiagnosed and misdiagnosed patients and their #healthcare ecosystems using IPM's Patient Finding and HCP Mapping.

Find out how. Find out now.

https://t.co/fB0ykseChr

[IPM.ai @ipm_ai]

The typical drug commercialization approach is falling short for specialty and rare conditions. https://t.co/aNpcekZuSB helps drive better decisions during the product lifecycle via augmented intelligence.

Find out how. Find out now. https://t.co/TWl34KCfWi

[IPM.ai @ipm_ai]

How do you focus on the highest value patient targets and maximize engagement channels with HCPs for disease interception and therapy education?

Found out how. Find out now.

#AugmentedIntelligence #CommericalEffectiveness #raredisease #pharma

https://t.co/9UbTgBOl65

[IPM.ai @ipm_ai]

https://t.co/aNpcekZuSB Recognized as One of the World’s Most Innovative Companies in 2022 by Fast Company
https://t.co/pE2bm4tvCa

[IPM.ai @ipm_ai]

Don't miss CEO Ron Elwell as he hosts an important discussion with all stars Michael R Crawford, Irene Dankwa-Mullan MD MPH and Evon Okidi on #healthequity and the use of inclusive #AI and the path to equitable #precisionmedicine.

#RealChemRHE https://t.co/DnOPRleAVV

[IPM.ai @ipm_ai]

We are honored to have been recognized by @PM360 as 2021 Innovative Startup! https://t.co/aNpcekZuSB is empowering the life sciences pioneers to make precision medicine an analytical reality.

#PatientFindingPioneers #precisionmedicine #RareDisease

https://t.co/4XrC5IxjB3

[IPM.ai @ipm_ai]

Learn how to drive better decisions during the product lifecycle via augmented intelligence and make the promise of #precisionmedicine an analytical reality. Download our whitepaper here! #PatientFindingPioneers #rarediseases #patientpopulations

https://t.co/InyAQ0SbqY

[IPM.ai @ipm_ai]

Missed our webinar? Curious to learn how https://t.co/aNpcekZuSB partnered w/ @KyowaKirin_US to uncover undiagnosed patients, better understand their diagnostic & treatment journey & map treating HCPs to target for disease education & therapy orientation? https://t.co/RVYZ7bCcN5

[IPM.ai @ipm_ai]

Conventional #clinicalstudy recruitment methods for #rarediseases don’t work. https://t.co/aNpcekZuSB accelerates #clinicalstudies of life saving therapies for rare conditions, leading to optimal commercial and patient outcomes quicker and with less risk. https://t.co/8drotwLVfC

[IPM.ai @ipm_ai]

Building a rare disease franchise? Register for our live webcast with @KyowaKirin_US where we'll discuss how https://t.co/aNpcekZuSB helped Kyowa Kirin to implement ML/AI-based patient finding to uncover undiagnosed patients. #PatientFindingPioneers https://t.co/qcFAmvwSFc

[IPM.ai @ipm_ai]

Learn how @johntgarcia sourced https://t.co/aNpcekZuSB to use #AI to better understand the clinical symptomatology of undiagnosed #patients suffering from a devastating rare disease.

#artificialintelligence #raredisease #realworlddata

https://t.co/MRfi4Ntgj5

[IPM.ai @ipm_ai]

Specialty and #raredisease drug development is one of the most active and fastest growing areas in drug R&D... Learn how https://t.co/aNpcekZuSB accelerates the successful development, study, launch and commercialization of #precisionmedicine.

https://t.co/UOgaozZznZ

[IPM.ai @ipm_ai]

The development, clinical study, launch and commercialization of specialty/rare disease therapies demands a new analytics approach, one very different from what is traditionally utilized for common conditions.
https://t.co/aNpcekZuSB #raredisease #orphandrugs #predictiveanalytics

[IPM.ai @ipm_ai]

With #RWD and modern analytical approaches utilizing #machinelearning and #artificialintelligence, we can observe the degree to which any HCP behaves like a defined specialty.

https://t.co/DhBCZFpE8l

[Rare Disease Day @rarediseaseday]

100s of patient organisations all over the world 🌏 organise events at a local and national level for #RareDiseaseDay

Discover the ones which make Rare Disease Day possible 🖐️💜

Rare is proud! 🦸

🔸 https://t.co/qFdKOza4ms

[IPM.ai @ipm_ai]

Our own Ron Elwell chats with W2O Group's Aaron Strout during W2O's 7th annual #digitalhealth summit. Join us as we explore how #artificialintelligence and #rwd can be utilized to overcome the challenges of commercializing therapies for #raredisease https://t.co/LLLhK0EaJD

[IPM.ai @ipm_ai]

@W2OGroup acquires #machinelearning, #artificialintelligence, and #rwd pioneers @Swoop and @ipm_ai, to power its new #healthtechnology business https://t.co/7Ry2GmlLac

[IPM.ai @ipm_ai]

“@W2OGroup brings @Swoop and @ipm_ai access to additional resources, health care expertise and opportunities to... help life sciences companies uncover, activate and ultimately engage their ideal patient populations and health networks” - Ron Elwell https://t.co/zdzyXsMfcg

[IPM.ai @ipm_ai]

@W2OGroup acquires #machinelearning, #artificialintelligence, and #rwd pioneers @Swoop and @ipm_ai to power its new #healthtechnology business https://t.co/5KRGJZ9NiN

[IPM.ai @ipm_ai]

We are excited to announce @ipm_ai's very own Graham Jones PhD and Julieanna Gubitosa as presenters at the All-Virtual 62nd #ASH20 Annual Meeting and Exposition. Can’t wait for you all to check it out! #predictiveanalytics #raredisease #datascience

https://t.co/xBgRqOkcUs